6-hydroxy Warfarin structure
|
Common Name | 6-hydroxy Warfarin | ||
---|---|---|---|---|
CAS Number | 17834-02-5 | Molecular Weight | 324.32700 | |
Density | 1.384 g/cm3 | Boiling Point | 540.2ºC at 760 mmHg | |
Molecular Formula | C19H16O5 | Melting Point | 119-120ºC | |
MSDS | Chinese USA | Flash Point | 197.7ºC | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Name | 6-Hydroxy Warfarin |
---|---|
Synonym | More Synonyms |
Density | 1.384 g/cm3 |
---|---|
Boiling Point | 540.2ºC at 760 mmHg |
Melting Point | 119-120ºC |
Molecular Formula | C19H16O5 |
Molecular Weight | 324.32700 |
Flash Point | 197.7ºC |
Exact Mass | 324.10000 |
PSA | 87.74000 |
LogP | 3.31520 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.659 |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H318 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R22 |
Safety Phrases | 26-39 |
RIDADR | NONH for all modes of transport |
HS Code | 2932209090 |
~47% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Obaseki, Andrew O.; Steffen, James E.; Porter, William R. Journal of Heterocyclic Chemistry, 1985 , vol. 22, p. 529 - 533 |
~% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Drug Metabolism and Disposition, , vol. 41, # 7 p. 1295 - 1299 |
~% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Journal of Heterocyclic Chemistry, , vol. 22, p. 529 - 533 |
~% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Journal of Heterocyclic Chemistry, , vol. 22, p. 529 - 533 |
~% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Journal of Heterocyclic Chemistry, , vol. 22, p. 529 - 533 |
~% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Journal of Heterocyclic Chemistry, , vol. 22, p. 529 - 533 |
~% 6-hydroxy Warfarin CAS#:17834-02-5 |
Literature: Journal of Heterocyclic Chemistry, , vol. 22, p. 529 - 533 |
HS Code | 2932209090 |
---|---|
Summary | 2932209090. other lactones. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Investigation of two-dimensional high performance liquid chromatography approaches for reversed phase resolution of warfarin and hydroxywarfarin isomers.
J. Chromatogr. A. 1363 , 200-6, (2014) Several offline and online 2D HPLC methods were investigated for the reversed phase resolution of a complex mixture of closely related warfarin and hydroxywarfarin isomers. By combining reversed phase... |
|
Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.
Chem. Res. Toxicol. 23(5) , 939-45, (2010) Coumadin (R/S-warfarin) anticoagulant therapy poses a risk to over 50 million Americans, in part due to interpersonal variation in drug metabolism. Consequently, it is important to understand how meta... |
|
Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins.
Drug Metab. Lett. 6(3) , 157-64, (2012) Coumadin (R/S-warfarin) is a highly efficacious and widely used anticoagulant; however, its highly variable metabolism remains an important contributor to uncertainties in therapeutic responses. Pharm... |
6-Hydroxywarfarin |
4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one |